[1]胡咏新 郑仁东 刘洲君 刘超.2017年骨质疏松年度进展[J].国际内分泌代谢杂志,2018,38(06):423-425.[doi:10.3760/cma.j.issn.1673-4157.2018.06.016]
 Hu Yongxin,Zheng Rendong,Liu Zhoujun,et al.Annual development of osteoporosis in 2017[J].International Journal of Endocrinology and Metabolism,2018,38(06):423-425.[doi:10.3760/cma.j.issn.1673-4157.2018.06.016]
点击复制

2017年骨质疏松年度进展()
分享到:

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
38
期数:
2018年06期
页码:
423-425
栏目:
基础研究
出版日期:
2018-11-20

文章信息/Info

Title:
Annual development of osteoporosis in 2017
作者:
胡咏新 郑仁东 刘洲君 刘超
作者单位:210028 南京中医药大学附属中西医结合医院内分泌代谢病分院,江苏省中医药研究院
Author(s):
Hu Yongxin Zheng Rendong Liu Zhoujun Liu Chao
Endocrine and Diabetes Center, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Traditional Chinese Medicine, Jiangsu Province Academy of Traditional Chinese Medcine, Nanjing 210028, China
关键词:
骨质疏松 诊断 治疗 年度进展
Keywords:
Osteoporosis Diagnosis Treatment Annual development
DOI:
10.3760/cma.j.issn.1673-4157.2018.06.016
摘要:
骨质疏松已成为威胁人类健康的严重社会问题,伴随发病率急剧上升,抗骨质疏松药物层出不穷,指南也在不断更新。回顾2017年,该病在诊断、筛查、干预及联合治疗等方面已取得长足发展。综述骨质疏松年度进展,对临床工作有所帮助。
Abstract:
Osteoporosis has become a serious social problem threatening human health, accompanied by a sharp rise in the incidence.Anti-osteoporosis drugs constantly developed, and the guide is constantly updated. In 2017, the diagnosis, screening, intervention and joint treatment of osteoporosis has made rapid progress. Therefore, the review of the annual progress of osteoporosis is helpful to the clinical work.

参考文献/References:


[1] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2017)[J]. 中华骨质疏松和骨矿盐疾病杂志,2017,10(5):413-443. DOI:10.3969/j.issn.1674-2591.2017.05.001.
[2] Batur P, Rice S, Barrios P,et al.Osteoporosis management[J].J Womens Health(Larchmt),2017,26(8):918-921.DOI:10.1089/jwh.2017.6496.
[3] Daly RM. Exercise and nutritional approaches to prevent frail bones, falls and fractures: an update[J].Climacteric,2017,20(2):119-124. DOI:10.1080/13697137.2017.1286890.
[4] Qaseem A,Forciea MA,McLean RM,et al.Treatment of low bone density or osteoporosis to prevent fractures in men and women: a clinical practice guideline update from the American college of physicians[J].Ann Intern Med,2017,166(11):818-839.DOI:10.7326/M15-1361.
[5] Cobin RH,Goodman NF,AACE Reproductive Endocrinology Scientific Committee,et al. American Association of Clinical Endocrinologists and American College of Endocrinology Position statement on menopause-2017 update[J].Endocr Pract,2017,23(7):869-880.DOI:10.4158/EP171828.PS.
[6] Woodruff TK,Khosla S.New hope for symptom management during natural and iatrogenic menopause transitions[J].Biol Reprod,2017,97(2):177-178.DOI:10.1093/biolre/iox079.
[7] Dede AD,Makras P,Anastasilakis AD. Investigational anabolic agents for the treatment of osteoporosis: an update on recent developments[J].Expert Opin Investig Drugs,2017,26(10):1137-1144.DOI:10.1080/13543784.2017.1371136.
[8] McClung MR.Using osteoporosis therapies in combination[J].Curr Osteoporos Rep,2017,15(4):343-352.DOI:10.1007/s11914-017-0376-x.

相似文献/References:

[1]孙敏讷,段宇.老年亚临床甲状腺功能减退症的诊治特点[J].国际内分泌代谢杂志,2014,(06):411.[doi:10.3760/cma.j.issn.1673-4157.2014.06.014]
 Sun Minne,Duan Yu..Diagnositc and therapeutic characteristics of subclinical hypothyroidism in elderly people[J].International Journal of Endocrinology and Metabolism,2014,(06):411.[doi:10.3760/cma.j.issn.1673-4157.2014.06.014]
[2]胡欣 陈国芳 刘超.男性迟发型性腺功能减退症的诊断与治疗[J].国际内分泌代谢杂志,2015,(01):59.[doi:10.3760/cma.j.issn.1673-4157.2015.01.015]
 Hu Xin,Chen Guofang,Liu Chao..Diagnosis and therapeutic options for late-onset hypogonadism in men[J].International Journal of Endocrinology and Metabolism,2015,(06):59.[doi:10.3760/cma.j.issn.1673-4157.2015.01.015]
[3]刘晓蓉 朱德发.糖尿病下肢动脉病变的诊断与治疗[J].国际内分泌代谢杂志,2015,(05):327.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.010]
 Liu Xiaorong*,Zhu Defa..Diagnosis and treatment of lower extremity arterial disease in diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(06):327.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.010]
[4]吴开泽 林文锋 方淑斌 张振.阿仑膦酸钠与特立帕肽不同联合方案治疗骨质疏松[J].国际内分泌代谢杂志,2015,(05):340.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.013]
 Wu Kaize*,Lin Wenfeng,Fang Shubin,et al.Different combination of alendronate and teriparatide in the treatment of osteoporosis[J].International Journal of Endocrinology and Metabolism,2015,(06):340.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.05.013]
[5]王海敏,汤旭磊.白藜芦醇对去卵巢骨质疏松大鼠血同型 半胱氨酸和氧化应激指标的影响[J].国际内分泌代谢杂志,2016,36(01):20.[doi:10.3760/cma.j.issn.1673-4157.2016.01.005]
 Wang Haimin,Tang Xulei..Effects of resveratrol on plasma homocysteine and oxidative stress in ovariectomized osteoporotic rats[J].International Journal of Endocrinology and Metabolism,2016,36(06):20.[doi:10.3760/cma.j.issn.1673-4157.2016.01.005]
[6]刘洲君,胡咏新,刘超.肠道益生菌对骨代谢的影响[J].国际内分泌代谢杂志,2016,36(01):55.[doi:10.3760/cma.j.issn.1673-4157.2016.01.014]
 Liu Zhoujun,Hu Yongxin,Liu Chao..Effects of intestinal probiotics on bone metabolism[J].International Journal of Endocrinology and Metabolism,2016,36(06):55.[doi:10.3760/cma.j.issn.1673-4157.2016.01.014]
[7]曹琳,刘超.妊娠糖尿病诊疗的争议与共识[J].国际内分泌代谢杂志,2016,36(03):176.[doi:10.3760/cma.j.issn.1673-4157.2016.03.08]
 Cao Lin,Liu Chao..Controversy and concensus on the diagnosis and treatment of gestational diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(06):176.[doi:10.3760/cma.j.issn.1673-4157.2016.03.08]
[8]冯娟,夏维波.维生素D结合蛋白研究进展[J].国际内分泌代谢杂志,2016,36(03):209.[doi:10.3760/cma.j.issn.1673-4157.2016.03.17]
 Feng Juan,Xia Weibo.Research progress of vitamin D binding protein[J].International Journal of Endocrinology and Metabolism,2016,36(06):209.[doi:10.3760/cma.j.issn.1673-4157.2016.03.17]
[9]毛斐,鹿斌,李益明.SUDOSCAN对糖尿病周围神经病变的诊断价值[J].国际内分泌代谢杂志,2016,36(05):331.[doi:10.3760/cma.j.issn.1673-4157.2016.05.12]
 Mao Fei,Lu Bin,Li Yiming.Diagnostic value of SUDOSCAN in detecting diabetic peripheral neuropathy[J].International Journal of Endocrinology and Metabolism,2016,36(06):331.[doi:10.3760/cma.j.issn.1673-4157.2016.05.12]
[10]孔晶,王鸥,邢小平.狄诺塞麦治疗代谢性骨病的研究进展[J].国际内分泌代谢杂志,2016,36(05):334.[doi:10.3760/cma.j.issn.1673-4157.2016.05.13]
 Kong Jing,Wang Ou,Xing Xiaoping.Update on denosumab treatment in metabolic bone diseases[J].International Journal of Endocrinology and Metabolism,2016,36(06):334.[doi:10.3760/cma.j.issn.1673-4157.2016.05.13]

备注/Memo

备注/Memo:
作者单位:210028 南京中医药大学附属中西医结合医院内分泌代谢病分院,江苏省中医药研究院
通信作者:刘超,Email: Liuchao@nfmcn.com
更新日期/Last Update: 2018-12-30